GW Pharmaceuticals

Latest articles

4d
FOX Business
5 Marijuana Stocks Overflowing With Cashwe're talking about the cash cows of marijuana, none has more on its balance sh
FOX Business / Posted 4 days ago
we're talking about the cash cows of marijuana, none has more on its balance sheet than cannabinoid-based drug developer GW Pharmaceuticals(NASDAQ: GWPH). According to the company's third-quarter report, it had $374.8 million in cash on its... Read more
3 related articles
4d
FOX Business
5 Marijuana Stocks Overflowing With Cashwe're talking about the cash cows of marijuana, none has more on its balance sh
FOX Business / Posted 4 days ago
we're talking about the cash cows of marijuana, none has more on its balance sheet than cannabinoid-based drug developer GW Pharmaceuticals(NASDAQ: GWPH). According to the company's third-quarter report, it had $374.8 million in cash on its... Read more
3 related articles
5d
FOX Business
Jeff Sessions May Soon Have a Green Light to Wage War on Medical-Marijuana Businessesidea. Furthermore, we've also seen some convincing evidence that marijuana can
FOX Business / Posted 5 days ago
idea. Furthermore, we've also seen some convincing evidence that marijuana can indeed be medicine for certain ailments. GW Pharmaceuticals(NASDAQ: GWPH), which is the largest marijuana stock by market cap, has had incredible success with its... Read more
3 related articles
5d
FOX Business
Jeff Sessions May Soon Have a Green Light to Wage War on Medical-Marijuana Businessesidea. Furthermore, we've also seen some convincing evidence that marijuana can
FOX Business / Posted 5 days ago
idea. Furthermore, we've also seen some convincing evidence that marijuana can indeed be medicine for certain ailments. GW Pharmaceuticals(NASDAQ: GWPH), which is the largest marijuana stock by market cap, has had incredible success with its... Read more
3 related articles
8d
FOX Business
Investors' Biggest Worry About GW Pharmaceuticals Could Be the Biotech's Ace in the HoleGW Pharmaceuticals' (NASDAQ: GWPH) stock soared more than 60% last year. So far
FOX Business / Posted 8 days ago
GW Pharmaceuticals' (NASDAQ: GWPH) stock soared more than 60% last year. So far in 2017, though, shares of the cannabinoid-focused biotech are down rather than up. One possible reason behind GW Pharma's lackluster year-to-date performance is that... Read more
14d
FOX Business
The 5 Worst Reasons to Buy Marijuana Stocksits risks and therefore generating a lot of money for pot stocks. Solid thesis,
FOX Business / Posted 14 days ago
its risks and therefore generating a lot of money for pot stocks. Solid thesis, right? On one hand, we have the example of GW Pharmaceuticals(NASDAQ: GWPH), which dazzled in multiple phase 3 trials with oral cannabidiol drug Epidiolex as a... Read more
14d
FOX Business
The 5 Worst Reasons to Buy Marijuana Stocksits risks and therefore generating a lot of money for pot stocks. Solid thesis,
FOX Business / Posted 14 days ago
its risks and therefore generating a lot of money for pot stocks. Solid thesis, right? On one hand, we have the example of GW Pharmaceuticals(NASDAQ: GWPH), which dazzled in multiple phase 3 trials with oral cannabidiol drug Epidiolex as a... Read more
19d
FOX Business
94% of Americans Support Legalizing Medical Marijuana, but Not Congressevidence via Food and Drug Administration-approved studies that cannabinoids ca
FOX Business / Posted 19 days ago
evidence via Food and Drug Administration-approved studies that cannabinoids can be helpful in treating certain ailments. GW Pharmaceuticals(NASDAQ: GWPH), the largest marijuana stock by market cap, has dazzled in late-stage studies with its lead... Read more
19d
FOX Business
94% of Americans Support Legalizing Medical Marijuana, but Not Congressevidence via Food and Drug Administration-approved studies that cannabinoids ca
FOX Business / Posted 19 days ago
evidence via Food and Drug Administration-approved studies that cannabinoids can be helpful in treating certain ailments. GW Pharmaceuticals(NASDAQ: GWPH), the largest marijuana stock by market cap, has dazzled in late-stage studies with its lead... Read more
23d
FOX Business
The Only Marijuana Stock to Rise by More Than 10% Last WeekZYN002 as a treatment for focal seizures in adult epilepsy patients leaves the
FOX Business / Posted 23 days ago
ZYN002 as a treatment for focal seizures in adult epilepsy patients leaves the door open for another company to follow in GW Pharmaceuticals' footsteps as a leading cannabinoid or cannabinoid receptor-targeting drug developer. Lastly, we... Read more
23d
FOX Business
The Only Marijuana Stock to Rise by More Than 10% Last WeekZYN002 as a treatment for focal seizures in adult epilepsy patients leaves the
FOX Business / Posted 23 days ago
ZYN002 as a treatment for focal seizures in adult epilepsy patients leaves the door open for another company to follow in GW Pharmaceuticals' footsteps as a leading cannabinoid or cannabinoid receptor-targeting drug developer. Lastly, we... Read more

In this news